We previously reported that intrathecal (i.t.)injections of TGF-β1 significantly inhibit neuropathy-induced thermal hyperalgesia, spinal microglia and astrocyte activation, as well as upregulation of tumor necrosis factor-α. Here, TGFB1 is linked to neuropathy.